Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases - Full Text View

Purpose

To assess the safety and efficacy of a single fraction of radiotherapy using helical tomotherapy to treat bone metastases.

Condition	Intervention	Phase
Bone Neoplasms	Procedure: Helical tomotherapy	Phase I

MedlinePlus related topics:

Bone Cancer Cancer

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Safety/Efficacy Study

Official Title:	Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases

Further study details as provided by Alberta Cancer Board:

Primary Outcome Measures:

To deliver a single fraction of radiotherapy safely to patients with bone metastases using helical tomotherapy

Secondary Outcome Measures:

To assess and quantify the acute toxicity of patients with bone metastases treated with helical tomotherapy.
To measure invivo dosimetry and compare delivered doses to computer-reconstructed dose distribution.
To determine the maximum tolerated does of palliative radiation give with helical tomotherpay in a single fraction.
To assess the efficacy (pain control) of radiotherapy given with helical tomotherapy.

Estimated Enrollment:	10
Study Start Date:	June 2001
Estimated Study Completion Date:	July 2005

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00168129

Sponsors and Collaborators

Alberta Cancer Board

Investigators


Principal Investigator:	Rufus Scrimger, MD	Alberta Cancer Board

More Information

Study ID Numbers:	NA-15-0007
First Received:	September 9, 2005
Last Updated:	November 6, 2006
ClinicalTrials.gov Identifier:	NCT00168129
Health Authority:	Canada: Ethics Review Committee

Keywords provided by Alberta Cancer Board:

tomotherapy

bone metastases

radiotherapy

intensity modulated

Study placed in the following topic categories:

Musculoskeletal Diseases

Bone Neoplasms

Bone neoplasms

Neoplasm Metastasis

Bone Diseases

Additional relevant MeSH terms:

Neoplastic Processes

Neoplasms

Pathologic Processes

Neoplasms by Site

ClinicalTrials.gov processed this record on September 22, 2008

Sponsored by:	Alberta Cancer Board
Information provided by:	Alberta Cancer Board
ClinicalTrials.gov Identifier:	NCT00168129